NCT01988558View on ClinicalTrials.gov

A Phase I/II to Assess Safety, Tolerability and Efficacy of DL-lactic Acid Syrup in Children With Recurrent Tonsillitis

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

August 31, 2016

Study Completion Date

September 30, 2016

Conditions

Recurrent Tonsillitis in Children

Interventions

DRUG

DL - Lactic Acid

Treated group to receive DL - Lactic Acid Syrup (Raspberry flavored)

DIETARY_SUPPLEMENT

Raspberry flavored syrup

Placebo group to receive Raspberry flavored Syrup

Trial Locations (3)

Unknown

Clalit Health Services, Pediatric Community Ambulatory Clinic, Petah Tikva

Clalit Health Services, Pediatric Community Ambulatory Ganei Hadar clinic, Petah Tikva

Assaf Harofeh Medical Center, Tzrifin

All Listed Sponsors

lead

Yali Pharmaceuticals

INDUSTRY

NCT01988558 - A Phase I/II to Assess Safety, Tolerability and Efficacy of DL-lactic Acid Syrup in Children With Recurrent Tonsillitis | Biotech Hunter | Biotech Hunter